SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007163
Filing Date
2021-05-14
Accepted
2021-05-14 08:14:19
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210331x10q.htm   iXBRL 10-Q 625555
2 EX-31.1 tmb-20210331xex31d1.htm EX-31.1 12354
3 EX-31.2 tmb-20210331xex31d2.htm EX-31.2 12302
4 EX-32.1 tmb-20210331xex32d1.htm EX-32.1 6862
5 EX-32.2 tmb-20210331xex32d2.htm EX-32.2 6834
  Complete submission text file 0001558370-21-007163.txt   2884359

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210331.xsd EX-101.SCH 29290
7 EX-101.CAL tmb-20210331_cal.xml EX-101.CAL 25220
8 EX-101.DEF tmb-20210331_def.xml EX-101.DEF 84019
9 EX-101.LAB tmb-20210331_lab.xml EX-101.LAB 260954
10 EX-101.PRE tmb-20210331_pre.xml EX-101.PRE 190201
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210331x10q_htm.xml XML 306463
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39811 | Film No.: 21922010
SIC: 2834 Pharmaceutical Preparations